Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High Glucose Induces Lipid Accumulation via 25-Hydroxycholesterol DNA-CpG Methylation

iScience(2020)10.1016/j.isci.2020.101102Source: DataRank Database

High Glucose Induces Lipid Accumulation via 25-Hydroxycholesterol DNA-CpG Methylation is a research paper published in iScience (2020). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 7.10)OA: goldTopics (22)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Lanming Chen ORCID,William M. Pandak,Douglas M. Heuman,Phillip B. Hylemon ORCID,Shunlin Ren ORCID

Live enrichment

PubMed:32408171 PMC:PMC7225732 OpenAlex:https://openalex.org/W3022007479

BLRD VA

Grant: I01 BX003656

BLRD VA

Grant: I01 BX000197

Virginia Commonwealth University

FWCI

7.10

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.cell.com/article/S258900422030287X/pdf

publisherhttp://www.cell.com/article/S258900422030287X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S258900422030287X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S258900422030287X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.isci.2020.101102

Fields of Study

Cholesterol and Lipid MetabolismLipid metabolism and biosynthesisDiet, Metabolism, and Disease

Keywords

DNA methylationLipid metabolismEpigeneticsDNMT1BiologyMethylationCarbohydrate metabolismFatty liverCpG siteDNA methyltransferaseBiochemistryCell biologyChemistryGene expressionGeneInternal medicineMolecular geneticssystems biologyBiological sciences

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study

10.6084/m9.figshare.21405806.v1figshare

Additional file 1 of Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study

10.6084/m9.figshare.21405806figshare

Additional file 2 of Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study

10.6084/m9.figshare.21405809.v1figshare

Additional file 2 of Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study

10.6084/m9.figshare.21405809figshare